Presenilin 2 (Alzheimer Disease 4) (PSEN2) (C-Term) Peptide
Quick Overview for Presenilin 2 (Alzheimer Disease 4) (PSEN2) (C-Term) Peptide (ABIN1541028)
Target
Origin
Source
Application
-
-
Protein Region
- C-Term
-
Sequence
- TAQERNEPIF PALIYSSAMV WTVGMAKLDP SSQGALQLPY DPEMEEDSYD
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-Psen2 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- Presenilin 2 (PSEN2) (Presenilin 2 (Alzheimer Disease 4) (PSEN2))
-
Background
-
This gene mutations in human homolog responsible for chromosome 1-linked familial Alzheimer's disease, expression increased during brain development but decreased in the adult.
Alias Symbols: -
Protein Size: 448 -
Molecular Weight
- 49 kDa
-
Gene ID
- 81751
-
NCBI Accession
- NM_031087, NP_112349
-
UniProt
- O88777
Target
-